Prices delayed by at least 15 minutes | Print
Ishares Iv PLC ISHARES NASDAQ US BIOTEC UCITS USD (ACC)
Open
$5.95
Previous close
$5.945
Trade high
$5.964
Year low
$5.25
Year high
$6.64
Replication method
Physical Full
Volume
2,505
Type
ETF
UCITS
Yes
Dividend yield
-
Ongoing charge
0.35
ISIN
IE00BYXG2H39
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Before investing please read:
Share price
Asset allocation
Top 10 holdings
Holdings 16/04/2024 | % of assets |
---|---|
Amgen Inc | 8.43 |
Vertex Pharmaceuticals Inc | 8.15 |
Gilead Sciences Inc | 8.12 |
Regeneron Pharmaceuticals Inc | 8.05 |
AstraZeneca PLC ADR | 4.41 |
Moderna Inc | 4.40 |
Biogen Inc | 3.15 |
Illumina Inc | 2.08 |
Alnylam Pharmaceuticals Inc | 2.05 |
Biomarin Pharmaceutical Inc | 1.90 |
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.